CA2018137A1 - Citrate magnesique de l-carnitine - Google Patents
Citrate magnesique de l-carnitineInfo
- Publication number
- CA2018137A1 CA2018137A1 CA2018137A CA2018137A CA2018137A1 CA 2018137 A1 CA2018137 A1 CA 2018137A1 CA 2018137 A CA2018137 A CA 2018137A CA 2018137 A CA2018137 A CA 2018137A CA 2018137 A1 CA2018137 A1 CA 2018137A1
- Authority
- CA
- Canada
- Prior art keywords
- magnesium citrate
- carnitine
- carnitine magnesium
- magnesium
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH2221/89 | 1989-06-14 | ||
CH222189 | 1989-06-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2018137A1 true CA2018137A1 (fr) | 1990-12-14 |
CA2018137C CA2018137C (fr) | 2000-01-11 |
Family
ID=4228693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002018137A Expired - Lifetime CA2018137C (fr) | 1989-06-14 | 1990-06-01 | Citrate magnesique de l-carnitine |
Country Status (9)
Country | Link |
---|---|
US (1) | US5071874A (fr) |
EP (1) | EP0402755B1 (fr) |
JP (1) | JP3023919B2 (fr) |
AT (1) | ATE93511T1 (fr) |
CA (1) | CA2018137C (fr) |
DD (1) | DD295155A5 (fr) |
DE (1) | DE59002438D1 (fr) |
DK (1) | DK0402755T3 (fr) |
ES (1) | ES2058680T3 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4027927A1 (de) * | 1990-09-04 | 1992-03-05 | Bayer Ag | Brausekomponente und verfahren zu ihrer herstellung |
RU2038077C1 (ru) * | 1992-06-26 | 1995-06-27 | Нонна Дмитриевна Кислякова | Средство, обладающее адаптогенной активностью |
AU1780395A (en) * | 1994-05-02 | 1995-11-09 | Omeara (Proprietary) Limited | Amino acid, carnitine and magnesium supplementation |
US5817329A (en) * | 1997-02-28 | 1998-10-06 | Gardiner; Paul T. | Nutritional supplement for increased muscle size and strength for body builders |
IT1291126B1 (it) * | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti sali non igroscopici della l-carnitina e delle alcanoil l-carnitine |
IT1291133B1 (it) * | 1997-04-07 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio tartrato |
IT1291134B1 (it) * | 1997-04-08 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato |
IT1291143B1 (it) * | 1997-04-18 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina |
IT1290600B1 (it) * | 1997-04-30 | 1998-12-10 | Sigma Tau Ind Farmaceuti | Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato |
WO2002017735A2 (fr) * | 2000-08-29 | 2002-03-07 | Lonza Ag | Procede de fabrication d'un melange pouvant etre granule et hydroxycitrate de carnitine et de magnesium |
DE10113446A1 (de) | 2001-03-19 | 2002-09-26 | Schwarzkopf Gmbh Hans | Haarbehandlungsmittel mit Betainen |
ITRM20020055A1 (it) * | 2002-02-04 | 2003-08-04 | Aldo Fassi | Sali metallici di carnitine, integratori dietetici/nutritivi che li contengono e kit dietetici per contrastare disturbi sessuali in soggetti |
ITMI20030315A1 (it) * | 2003-02-21 | 2004-08-22 | Vama Farmacosmetica S R L | Sale di carnitina, preliposoma che lo contiene e formulato dermocosmetico per uso topico a base del detto sale di carnitina. |
CN101912045B (zh) * | 2005-07-05 | 2013-07-31 | 隆萨股份公司 | 生产干肉碱粉末或颗粒的喷雾干燥法 |
DE102005062360A1 (de) | 2005-12-23 | 2007-06-28 | Henkel Kgaa | Haarfärbeverfahren |
EP1862163A1 (fr) * | 2006-05-12 | 2007-12-05 | Verla-Pharm Arzneimittelfabrik Apotheker H.J. von Ehrlich GmbH & Co. KG | L-carnitine pour la supression de la cristallisation |
EP1854453B1 (fr) * | 2006-05-12 | 2011-02-16 | Verla-Pharm Arzneimittelfabrik Apotheker H.J. von Ehrlich GmbH & Co. KG | Composition aqueuse avec stabilité au stockage comprenant une composé du magnesium et du L-carnitine |
CN101209975B (zh) | 2006-12-29 | 2010-12-01 | 沈阳科硕营养科技有限公司 | 左旋肉碱富马酸钙及其制备方法与用途 |
EP2206440A1 (fr) * | 2008-12-24 | 2010-07-14 | Taminco | Processus de préparation d'une poudre à écoulement libre d'un composé d'ammoniac quaternaire déliquescent |
CN102911067A (zh) * | 2011-08-04 | 2013-02-06 | 广州市奥海生物科技有限公司 | 左旋肉碱丙酮酸盐及其制备方法与用途 |
CN102911068A (zh) * | 2011-08-04 | 2013-02-06 | 广州市奥海生物科技有限公司 | 左旋肉碱l-苹果酸盐及其制备方法与用途 |
CN102911069A (zh) * | 2011-08-04 | 2013-02-06 | 广州市奥海生物科技有限公司 | 左旋肉碱柠檬酸钙及其制备方法与用途 |
CN103922949A (zh) * | 2014-04-29 | 2014-07-16 | 吉林大学 | 一种亮氨酸鳌合钙粉及加工方法 |
KR101721145B1 (ko) * | 2015-07-29 | 2017-03-29 | 제너럴바이오(주) | L-카르니틴 구연산 마그네슘을 포함하는 배변촉진 겸용 다이어트용 식품 조성물 |
IL261670B (en) * | 2018-09-06 | 2019-06-30 | Tudu Holdings Ltd | Magnesium-containing formulation and uses thereof |
CN111990574A (zh) * | 2020-09-18 | 2020-11-27 | 内蒙古精晶生物科技有限公司 | 一种左旋肉碱营养泡腾片 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE23217C (de) * | 1900-01-01 | F. E. CANDA in New-York | Zapfenlager aus Amalgam | |
FR4608M (fr) * | 1965-04-02 | 1966-11-21 | ||
GB1153640A (en) * | 1967-04-10 | 1969-05-29 | Soc D Etudes Prod Chimique | A Carnitin Salt |
US3810994A (en) * | 1972-06-01 | 1974-05-14 | Ethyl Corp | Method and composition for treating obesity |
US4172072A (en) * | 1977-10-20 | 1979-10-23 | Ashmead H H | Buffered enzymatically produced metal proteinates |
DE2903558C2 (de) * | 1978-02-03 | 1994-09-01 | Sigma Tau Ind Farmaceuti | Verwendung von L-Carnitin |
IT1142201B (it) * | 1980-06-24 | 1986-10-08 | Sigma Tau Ind Farmaceuti | Procedimento per la produzione enzimatica di l-carnitina |
JPS57126420A (en) * | 1981-01-26 | 1982-08-06 | Eiji Murakami | Drug for digestive organ |
DE3463261D1 (en) * | 1983-12-28 | 1987-05-27 | Sigma Tau Ind Farmaceuti | Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same |
US4537772A (en) * | 1984-05-02 | 1985-08-27 | Merck & Co., Inc. | Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines |
US4855289A (en) * | 1984-06-04 | 1989-08-08 | Wester Per O | Combination of two active substances |
IT1209564B (it) * | 1984-06-29 | 1989-08-30 | Magis Farmaceutici | Derivati della l-carnitina o di l-acil carnitina. |
IT1190280B (it) * | 1986-04-24 | 1988-02-16 | Sigma Tau Ind Farmaceuti | Procedimento per la preparazione di gamma-butirrobetaina |
US4871550A (en) * | 1986-09-05 | 1989-10-03 | Millman Phillip L | Nutrient composition for athletes and method of making and using the same |
US4895980A (en) * | 1988-01-05 | 1990-01-23 | Mission Pharmacal Company, Inc. | Method of manufacturing magnesium potassium citrate |
JP3604736B2 (ja) * | 1994-06-30 | 2004-12-22 | 株式会社トーア | 外壁工法 |
JPH0824889A (ja) * | 1994-07-19 | 1996-01-30 | Hitachi Ltd | 噴水曝気型水質浄化装置 |
-
1990
- 1990-06-01 CA CA002018137A patent/CA2018137C/fr not_active Expired - Lifetime
- 1990-06-06 EP EP90110725A patent/EP0402755B1/fr not_active Expired - Lifetime
- 1990-06-06 DE DE90110725T patent/DE59002438D1/de not_active Expired - Lifetime
- 1990-06-06 AT AT90110725T patent/ATE93511T1/de not_active IP Right Cessation
- 1990-06-06 ES ES90110725T patent/ES2058680T3/es not_active Expired - Lifetime
- 1990-06-06 DK DK90110725.0T patent/DK0402755T3/da active
- 1990-06-11 JP JP2152507A patent/JP3023919B2/ja not_active Expired - Fee Related
- 1990-06-12 DD DD90341543A patent/DD295155A5/de not_active IP Right Cessation
- 1990-06-13 US US07/537,989 patent/US5071874A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
DK0402755T3 (da) | 1993-10-04 |
DE59002438D1 (de) | 1993-09-30 |
ES2058680T3 (es) | 1994-11-01 |
EP0402755A3 (fr) | 1991-01-16 |
JP3023919B2 (ja) | 2000-03-21 |
CA2018137C (fr) | 2000-01-11 |
EP0402755B1 (fr) | 1993-08-25 |
EP0402755A2 (fr) | 1990-12-19 |
ATE93511T1 (de) | 1993-09-15 |
JPH0324010A (ja) | 1991-02-01 |
US5071874A (en) | 1991-12-10 |
DD295155A5 (de) | 1991-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2018137A1 (fr) | Citrate magnesique de l-carnitine | |
EP1164132A3 (fr) | Omeprazole de magnésium cristallin | |
AU6431890A (en) | New esters of thienyl carboxylic acids and amino alcohols, their quaternization products, and the manufacture and use of said compounds | |
CA2094879A1 (fr) | Procede de fabrication de comprimes pour boissons et produits derives | |
CA2116942A1 (fr) | Produit refrigere contenant des morceaux de chocolat, methode et dispositif pour sa production | |
EP0259139A3 (en) | Novel pyridinylpyrimidine derivatives, method for production thereof and a plant disease protectant containing them as the active ingredient | |
CA2322473A1 (fr) | Complexe de calcium et aliment enrichi en calcium | |
CA2000763A1 (fr) | Produit dispersant | |
CA2171435A1 (fr) | Matiere granulaire effervescente et mode de preparation connexe | |
IL88908A0 (en) | 3,5-dihydroxy carboxylic acid and derivatives thereof,a process for the preparation thereof,the use thereof as pharmaceuticals,pharmaceutical products and intermediates | |
CA2078939A1 (fr) | Sels stables de l'acide 5,10-methylenetetrahydrofolique | |
CA2162470A1 (fr) | Comprime a biodisponibilite amelioree, renfermant de l'acide dichloromethylenediphosphonique comme principe actif | |
CA2083243A1 (fr) | Procede de fabrication d'un concentre de thrombine exempt de virus | |
CA2035841A1 (fr) | Presentations orales de sulfate de glucosamine stables a l'entreposage et mode de fabrication | |
CA2027341A1 (fr) | Procede de preparation de l'acide 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylique et ses derives | |
CA1269671C (fr) | ||
AU3674989A (en) | Process for the preparation of 2,6-dichlorodiphenylaminoacetic acid derivatives | |
EP0432910A3 (en) | Process for producing highly pure 2, 6 naphthalene dicarboxylic acid | |
HUT54166A (en) | Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
GR3004863T3 (fr) | ||
CA2030344A1 (fr) | Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines | |
CA2136071A1 (fr) | Compositions d'acide 2-arylpropionique et mode de preparation | |
HUT46364A (en) | Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient | |
CA2345006A1 (fr) | Nouveaux derives de benzoylguanidine aux proprietes avantageuses, leur procede de production et leur utilisation dans la production de compositions pharmaceutiques | |
IE810808L (en) | Isophthalic acid picolylamide monohydrate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |